Cargando…
Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study
PURPOSE: Totally implantable venous access devices (TIVADs) currently have an important place in medical oncology practice; however, their long-term availability deserves further investigation, since they are usually required by patients for prolonged periods. This study aimed to evaluate long-term...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163709/ https://www.ncbi.nlm.nih.gov/pubmed/33155092 http://dx.doi.org/10.1007/s00520-020-05871-6 |
_version_ | 1783700959887622144 |
---|---|
author | Tumay, Latif Volkan Guner, Osman Serhat |
author_facet | Tumay, Latif Volkan Guner, Osman Serhat |
author_sort | Tumay, Latif Volkan |
collection | PubMed |
description | PURPOSE: Totally implantable venous access devices (TIVADs) currently have an important place in medical oncology practice; however, their long-term availability deserves further investigation, since they are usually required by patients for prolonged periods. This study aimed to evaluate long-term availability of TIVADs in adult cancer patients, in conjunction with complication/removal rates over time and associated risk factors during 7-year follow-up. METHODS: A total of 204 adult cancer patients who underwent TIVAD placement via subclavian vein using the Seldinger technique were included in this study. Medical data and catheter follow-up records were investigated retrospectively. Complications and port removals due to complications were evaluated over time. RESULTS: During median 21.9 (range, 0.7–82.9) months of follow-up, great majority of the patients did not require catheter removal due to complications (91.7%). During a total follow-up of 183,328 catheter days, 20 (9.8%) patients had complications with an incidence of 0.109 cases per 1000 catheter days and 18 (8.8%) of them required TIVAD removal (0.098 cases per 1000 catheter days). Most device removals due to complications (15/18, 83.3%) occurred within the first 24 months. Multivariate analysis identified left-sided device location as the only significant independent predictor of short device availability (OR, 3.5 [95% CI, 1.1–11.1], p = 0.036). CONCLUSION: TIVADs in cancer patients appear to be safe and their availability appears to be high in the long term. A decision for early removal might be revisited. Opting for the accustomed side (right side in the present study) for implantations seems to be associated with better outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-020-05871-6. |
format | Online Article Text |
id | pubmed-8163709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81637092021-06-17 Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study Tumay, Latif Volkan Guner, Osman Serhat Support Care Cancer Original Article PURPOSE: Totally implantable venous access devices (TIVADs) currently have an important place in medical oncology practice; however, their long-term availability deserves further investigation, since they are usually required by patients for prolonged periods. This study aimed to evaluate long-term availability of TIVADs in adult cancer patients, in conjunction with complication/removal rates over time and associated risk factors during 7-year follow-up. METHODS: A total of 204 adult cancer patients who underwent TIVAD placement via subclavian vein using the Seldinger technique were included in this study. Medical data and catheter follow-up records were investigated retrospectively. Complications and port removals due to complications were evaluated over time. RESULTS: During median 21.9 (range, 0.7–82.9) months of follow-up, great majority of the patients did not require catheter removal due to complications (91.7%). During a total follow-up of 183,328 catheter days, 20 (9.8%) patients had complications with an incidence of 0.109 cases per 1000 catheter days and 18 (8.8%) of them required TIVAD removal (0.098 cases per 1000 catheter days). Most device removals due to complications (15/18, 83.3%) occurred within the first 24 months. Multivariate analysis identified left-sided device location as the only significant independent predictor of short device availability (OR, 3.5 [95% CI, 1.1–11.1], p = 0.036). CONCLUSION: TIVADs in cancer patients appear to be safe and their availability appears to be high in the long term. A decision for early removal might be revisited. Opting for the accustomed side (right side in the present study) for implantations seems to be associated with better outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-020-05871-6. Springer Berlin Heidelberg 2020-11-05 2021 /pmc/articles/PMC8163709/ /pubmed/33155092 http://dx.doi.org/10.1007/s00520-020-05871-6 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Tumay, Latif Volkan Guner, Osman Serhat Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title | Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title_full | Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title_fullStr | Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title_full_unstemmed | Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title_short | Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
title_sort | availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163709/ https://www.ncbi.nlm.nih.gov/pubmed/33155092 http://dx.doi.org/10.1007/s00520-020-05871-6 |
work_keys_str_mv | AT tumaylatifvolkan availabilityoftotallyimplantablevenousaccessdevicesincancerpatientsishighinthelongtermasevenyearfollowupstudy AT gunerosmanserhat availabilityoftotallyimplantablevenousaccessdevicesincancerpatientsishighinthelongtermasevenyearfollowupstudy |